Cover Image
Market Research Report

Global Pre-filled Syringes Market Research Report, Insights, Opportunity Analysis, Market Shares and Forecast, 2017 -2023

Published by Occams Business Research & Consulting Pvt. Ltd. Product code 609647
Published Content info 190 Pages
Delivery time: Inquiry
Price
Back to Top
Global Pre-filled Syringes Market Research Report, Insights, Opportunity Analysis, Market Shares and Forecast, 2017 -2023
Published: March 1, 2018 Content info: 190 Pages
Description

The global prefilled syringe market is expected to grow with the CAGR of over 10% during forecast period 2016-2023. Prefilled syringe are novel medical devices that are used to deliver vaccines, drugs, biologics etc. The major driver for the growth of global prefilled syringes market is increasing prevalence chronic disease such as diabetes, rheumatoid arthritis, cancer etc. increasing adoption of self-injection devices such as pen injectors, technological advancements in the drug delivery platforms and superior effectiveness of the prefilled syringes. However, easy availability of alternative products i.e. vials, ampules and stringent government regulations on the manufacturing of prefilled syringes are the major factor that impede the growth of global prefilled syringe market.

The global prefilled syringe market report covers segmentation analysis of application, material and design. The application segment is further segmented into diabetes, anaphylaxis, arthritis and others. The material segment is further segmented into glass based and plastic based. The diabetes segment dominates the application segment in 2016 owing to high adoption of prefilled syringes in the diagnosis of diabetes primarily due to significant reduction in medical errors and increasing prevalence of home-based care. In the glass based prefilled syringe dominated the material segment in 2016.

Geographically, North America and Europe region dominated the global prefilled syringe market, moreover Asia Pacific is expected to grow with the highest CAGR over the forecast period of 2016-2023. The North America and Europe prefilled syringe is primarily driven by growing geriatric population, demand for quality healthcare, increasing trend of home-based treatment coupled with high healthcare expenditure in these regions that has facilitated wide adoption of prefilled syringes. Asia Pacific prefilled syringe market is primarily driven by rising geriatric population coupled with the demand of improved healthcare backed up by increasing healthcare expenditure.

The key players in the global prefilled syringe market are Gerresheimer (Germany), Nipro Pharma Corporation (Vietnam), Unilife Corporation (Us), Weigao Group (China) and others. These companies are adopting various strategies such as merger & acquisition, collaboration, partnership and product launch. Whereas, acquisition is the key strategy adopted by companies in global prefilled syringe market. For instance, in 2016 Cardinal health acquired medical supplies business of Medtronic for $ 6.1 billion. The medical supplies business includes bandages, prefilled syringes, and catheters etc. This portfolio acquisition will enable cardinal to increase product breadth of cardinal in consumable medical products as well as further increase geographic scale and enhance channel access in the untapped market.

Table of Contents
Product Code: HME-9430318

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. EXECUTIVE SUMMARY
  • 1.2. ESTIMATION METHODOLOGY

2. MARKET OVERVIEW

  • 2.1. GLOBAL PREFILLED SYRINGES MARKET: EVOLUTION & TRANSITION
  • 2.2. INDUSTRY STRUCTURE
  • 2.3. REGULATORY FRAMEWORK
  • 2.4. TOTAL MARKET ANALYSIS
    • 2.4.1. TOP 5 FINDINGS
    • 2.4.2. TOP 5 OPPORTUNITY MARKETS
    • 2.4.3. TOP 5 COMPANIES
    • 2.4.4. TOP 3 COMPETITIVE STRATEGIES
  • 2.5. ESTIMATION ANALYSIS
  • 2.6. STRATEGIC ANALYSIS
    • 2.6.1. INVESTMENT VS. ADOPTION MODEL
    • 2.6.2. 360 DEGREE INDUSTRY ANALYSIS
    • 2.6.3. PORTERS 5 FORCE MODEL
    • 2.6.4. SEE-SAW ANALYSIS
    • 2.6.5. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
  • 2.7. COMPETITIVE ANALYSIS
    • 2.7.1. MARKET SHARE ANALYSIS
    • 2.7.2. TOP COMPANY ANALYSIS
  • 2.8. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
    • 2.8.1. INVESTMENT OPPORTUNITIES BY REGIONS
    • 2.8.2. OPPORTUNITIES IN EMERGING APPLICATIONS
    • 2.8.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT

3. MARKET DETERMINANTS

  • 3.1. MARKET DRIVERS
    • 3.1.1. INCREASING PREVALENCE OF CHRONIC DISEASES ACROSS THE GLOBE
    • 3.1.2. HELPFUL TO REDUCE MEDICATION ERRORS
    • 3.1.3. INCREASING USE OF SELF-INJECTION DEVICES
    • 3.1.4. TECHNOLOGICAL INNOVATIONS
  • 3.2. MARKET RESTRAINTS
    • 3.2.1. EASY AVAILABILITY OF ALTERNATIVE PRODUCTS
    • 3.2.2. STRINGENT GOVERNMENT REGULATIONS
  • 3.3. MARKET OPPORTUNITIES
    • 3.3.1. GROWING DEMAND FROM EMERGING ECONOMIES
    • 3.3.2. INCREASING DEMAND FOR HOME-BASED HEALTHCARE TREATMENT
  • 3.4. MARKET CHALLENGES
    • 3.4.1. NEGATIVE EFFECTS SUCH AS FATAL INFECTIONS ASSOCIATED WITH THE USE OF PREFILLED SYRINGES
    • 3.4.2. HIGH COST ASSOCIATED WITH THE PRODUCTION OF PREFILLED SYRINGES

4. MARKET SEGMENTATION

  • 4.1. GLOBAL PREFILLED SYRINGES MARKET BY APPLICATION
    • 4.1.1. MARKET DEFINITION AND SCOPE
    • 4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.1.4. OPPORTUNITY MATRIX
    • 4.1.5. MARKET SEGMENTATION
      • 4.1.5.1. GLOBAL PREFILLED SYRINGES HORMONE REPLACEMENT MARKET
        • 4.1.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION) TOP PLAYERS & KEY PRODUCTS
        • 4.1.5.1.3. KEY CONCLUSIONS
      • 4.1.5.2. GLOBAL PREFILLED SYRINGES DIABETES MARKET
        • 4.1.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION) TOP PLAYERS & KEY PRODUCTS
        • 4.1.5.2.3. KEY CONCLUSIONS
      • 4.1.5.3. GLOBAL PREFILLED SYRINGES ANAPHYLAXIS MARKET
        • 4.1.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.1.5.3.3. TOP PLAYERS & KEY PRODUCTS
        • 4.1.5.3.4. KEY CONCLUSIONS
      • 4.1.5.4. GLOBAL PREFILLED SYRINGES ARTHRITIS MARKET
        • 4.1.5.4.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.4.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.1.5.4.3. TOP PLAYERS & KEY PRODUCTS
        • 4.1.5.4.4. KEY CONCLUSIONS
      • 4.1.5.5. GLOBAL PREFILLED SYRINGES ANEMIA MARKET
        • 4.1.5.5.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.5.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.1.5.5.3. TOP PLAYERS & KEY PRODUCTS
        • 4.1.5.5.4. KEY CONCLUSIONS
      • 4.1.5.6. GLOBAL PREFILLED SYRINGES MULTIPLE SCLEROSIS MARKET
        • 4.1.5.6.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.6.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.1.5.6.3. TOP PLAYERS & KEY PRODUCTS
        • 4.1.5.6.4. KEY CONCLUSIONS
  • 4.2. GLOBAL PREFILLED SYRINGES MARKET BY MATERIAL
    • 4.2.1. MARKET DEFINITION AND SCOPE
    • 4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.2.4. OPPORTUNITY MATRIX
    • 4.2.5. MARKET SEGMENTATION
      • 4.2.5.1. GLOBAL PREFILLED SYRINGES GLASS-BASED MARKET
        • 4.2.5.1.1. APPLICATION
        • 4.2.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.2.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.2.5.1.4. TOP PLAYERS & KEY PRODUCTS
        • 4.2.5.1.5. KEY CONCLUSIONS
      • 4.2.5.2. GLOBAL PREFILLED SYRINGES PLASTIC-BASED MARKET
        • 4.2.5.2.1. APPLICATION
        • 4.2.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.2.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.2.5.2.4. TOP PLAYERS & KEY PRODUCTS
        • 4.2.5.2.5. KEY CONCLUSIONS
  • 4.3. GLOBAL PREFILLED SYRINGES MARKET BY DISTRIBUTION CHANNEL
    • 4.3.1. MARKET DEFINITION AND SCOPE
    • 4.3.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.3.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.3.4. OPPORTUNITY MATRIX
    • 4.3.5. MARKET SEGMENTATION
      • 4.3.5.1. GLOBAL PREFILLED SYRINGES HOSPITALS MARKET
        • 4.3.5.1.1. APPLICATION
        • 4.3.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.3.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.3.5.1.4. TOP PLAYERS & KEY PRODUCTS
        • 4.3.5.1.5. KEY CONCLUSIONS
      • 4.3.5.2. GLOBAL PREFILLED SYRINGES AMBULATORY SURGICAL CENTERS MARKET
        • 4.3.5.2.1. APPLICATION
        • 4.3.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.3.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.3.5.2.4. TOP PLAYERS & KEY PRODUCTS
        • 4.3.5.2.5. KEY CONCLUSIONS
      • 4.3.5.3. GLOBAL PREFILLED SYRINGES MAIL ORDER PHARMACIES MARKET
        • 4.3.5.3.1. APPLICATION
        • 4.3.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.3.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.3.5.3.4. TOP PLAYERS & KEY PRODUCTS
        • 4.3.5.3.5. KEY CONCLUSIONS

5. COMPETITIVE LANDSCAPE

  • 5.1. KEY STRATEGIES
    • 5.1.1. LIST OF MERGER &ACQUISTION
    • 5.1.2. LIST OF JOINT VENTURES
    • 5.1.3. LIST OF PRODUCT LAUNCHES
    • 5.1.4. LIST OF PARTNERSHIP
  • 5.2. TOP 10 COMPANY ANALYSIS

6. GEOGRAPHICAL ANALYSIS

  • 6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
  • 6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
  • 6.3. OPPORTUNITY MATRIX
  • 6.4. GLOBAL PREFILLED SYRINGES MARKET BY REGION 2014-2023 ($ MILLION)
    • 6.4.1. NORTH AMERICA
      • 6.4.1.1. INDUSTRIAL APPLICATION ANALYSIS 2014-2023 ($ MILLION)
      • 6.4.1.2. TOP COUNTRY ANALYSIS
        • 6.4.1.2.1. U.S.
          • 6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.1.2.1.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.1.2.1.3. KEY CONCLUSIONS
        • 6.4.1.2.2. CANADA
          • 6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.1.2.2.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.1.2.2.3. KEY CONCLUSIONS
    • 6.4.2. EUROPE
      • 6.4.2.1. INDUSTRY APPLICATION ANALYSIS 2014-2023 ($ MILLION)
      • 6.4.2.2. TOP COUNTRY ANALYSIS
        • 6.4.2.2.1. UK
          • 6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.1.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.1.3. KEY CONCLUSIONS
        • 6.4.2.2.2. FRANCE
          • 6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.2.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.2.3. KEY CONCLUSIONS
        • 6.4.2.2.3. GERMANY
          • 6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.3.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.3.3. KEY CONCLUSIONS
        • 6.4.2.2.4. SPAIN
          • 6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.4.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.4.3. KEY CONCLUSIONS
        • 6.4.2.2.5. REST OF EUROPE
          • 6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.5.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.5.3. KEY CONCLUSIONS
    • 6.4.3. ASIA PACIFIC
      • 6.4.3.1. INDUSTRY APPLICATION ANALYSIS 2014-2023 ($ MILLION)
      • 6.4.3.2. TOP COUNTRY ANALYSIS
        • 6.4.3.2.1. CHINA
          • 6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.1.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.1.3. KEY CONCLUSIONS
        • 6.4.3.2.2. INDIA
          • 6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.2.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.2.3. KEY CONCLUSIONS
        • 6.4.3.2.3. JAPAN
          • 6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.3.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.3.3. KEY CONCLUSIONS
        • 6.4.3.2.4. SOUTH KOREA
          • 6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.4.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.4.3. KEY CONCLUSIONS
        • 6.4.3.2.5. REST OF ASIA PACIFIC
          • 6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.5.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.5.3. KEY CONCLUSIONS
    • 6.4.4. ROW
      • 6.4.4.1. INDUSTRY APPLICATION ANALYSIS 2014-2023 ($ MILLION)
      • 6.4.4.2. TOP COUNTRY ANALYSIS
        • 6.4.4.2.1. LATIN AMERICA
          • 6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.4.2.1.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.4.2.1.3. KEY CONCLUSIONS
        • 6.4.4.2.2. MIDDLE EAST & AFRICA
          • 6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.4.2.2.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.4.2.2.3. KEY CONCLUSIONS

7. COMPANY PROFILES

  • 7.1. BAXTER INTERNATIONAL. (U.S.)
    • 7.1.1. OVERVIEW
    • 7.1.2. PRODUCT PORTFOLIO
    • 7.1.3. KEY INNOVATION SECTOR
    • 7.1.4. STRATEGIC INITIATIVES
    • 7.1.5. SCOT ANALYSIS
    • 7.1.6. STRATEGIC ANALYSIS
  • 7.2. BECTON DICKINSON & CO.(U.S.)
    • 7.2.1. OVERVIEW
    • 7.2.2. PRODUCT PORTFOLIO
    • 7.2.3. KEY INNOVATION SECTOR
    • 7.2.4. STRATEGIC INITIATIVES
    • 7.2.5. SCOT ANALYSIS
    • 7.2.6. STRATEGIC ANALYSIS
  • 7.3. CARDINAL HEALTH. (U.S.)
    • 7.3.1. OVERVIEW
    • 7.3.2. PRODUCT PORTFOLIO
    • 7.3.3. KEY INNOVATION SECTOR
    • 7.3.4. STRATEGIC INITIATIVES
    • 7.3.5. SCOT ANALYSIS
    • 7.3.6. STRATEGIC ANALYSIS
  • 7.4. CATELENT INC.(U.S.)
    • 7.4.1. OVERVIEW
    • 7.4.2. PRODUCT PORTFOLIO
    • 7.4.3. KEY INNOVATION SECTOR
    • 7.4.4. STRATEGIC INITIATIVES
    • 7.4.5. SCOT ANALYSIS
    • 7.4.6. STRATEGIC ANALYSIS
  • 7.5. GERRESHEIMER. (GERMANY)
    • 7.5.1. OVERVIEW
    • 7.5.2. PRODUCT PORTFOLIO
    • 7.5.3. KEY INNOVATION SECTOR
    • 7.5.4. STRATEGIC INITIATIVES
    • 7.5.5. SCOT ANALYSIS
    • 7.5.6. STRATEGIC ANALYSIS
  • 7.6. MEDTRONIC. (U.S.)
    • 7.6.1. OVERVIEW
    • 7.6.2. PRODUCT PORTFOLIO
    • 7.6.3. KEY INNOVATION SECTOR
    • 7.6.4. STRATEGIC INITIATIVES
    • 7.6.5. SCOT ANALYSIS
    • 7.6.6. STRATEGIC ANALYSIS
  • 7.7. NIPRO PHARMA CORPORATION. (JAPAN)
    • 7.7.1. OVERVIEW
    • 7.7.2. PRODUCT PORTFOLIO
    • 7.7.3. KEY INNOVATION SECTOR
    • 7.7.4. STRATEGIC INITIATIVES
    • 7.7.5. SCOT ANALYSIS
    • 7.7.6. STRATEGIC ANALYSIS
  • 7.8. OMNI PHARMA. (ITALY)
    • 7.8.1. OVERVIEW
    • 7.8.2. PRODUCT PORTFOLIO
    • 7.8.3. KEY INNOVATION SECTOR
    • 7.8.4. STRATEGIC INITIATIVES
    • 7.8.5. SCOT ANALYSIS
    • 7.8.6. STRATEGIC ANALYSIS
  • 7.9. ROCHE DIAGNOSTICS. (U.S.)
    • 7.9.1. OVERVIEW
    • 7.9.2. PRODUCT PORTFOLIO
    • 7.9.3. KEY INNOVATION SECTOR
    • 7.9.4. STRATEGIC INITIATIVES
    • 7.9.5. SCOT ANALYSIS
    • 7.9.6. STRATEGIC ANALYSIS
  • 7.10. SCHOTT AG. (GERMANY)
    • 7.10.1. OVERVIEW
    • 7.10.2. PRODUCT PORTFOLIO
    • 7.10.3. KEY INNOVATION SECTOR
    • 7.10.4. STRATEGIC INITIATIVES
    • 7.10.5. SCOT ANALYSIS
    • 7.10.6. STRATEGIC ANALYSIS
  • 7.11. TERUMO MEDICAL CORPORATION. (U.S.)
    • 7.11.1. OVERVIEW
    • 7.11.2. PRODUCT PORTFOLIO
    • 7.11.3. KEY INNOVATION SECTOR
    • 7.11.4. STRATEGIC INITIATIVES
    • 7.11.5. SCOT ANALYSIS
    • 7.11.6. STRATEGIC ANALYSIS
  • 7.12. UNILIFE CORPORATION. (U.S.)
    • 7.12.1. OVERVIEW
    • 7.12.2. PRODUCT PORTFOLIO
    • 7.12.3. KEY INNOVATION SECTOR
    • 7.12.4. STRATEGIC INITIATIVES
    • 7.12.5. SCOT ANALYSIS
    • 7.12.6. STRATEGIC ANALYSIS
  • 7.13. VETTER PHARMA. (GERMANY)
    • 7.13.1. OVERVIEW
    • 7.13.2. PRODUCT PORTFOLIO
    • 7.13.3. KEY INNOVATION SECTOR
    • 7.13.4. STRATEGIC INITIATIVES
    • 7.13.5. SCOT ANALYSIS
    • 7.13.6. STRATEGIC ANALYSIS
  • 7.14. WEIGAO GROUP. (CHINA)
    • 7.14.1. OVERVIEW
    • 7.14.2. PRODUCT PORTFOLIO
    • 7.14.3. KEY INNOVATION SECTOR
    • 7.14.4. STRATEGIC INITIATIVES
    • 7.14.5. SCOT ANALYSIS
    • 7.14.6. STRATEGIC ANALYSIS
  • 7.15. WEST PHARMA. (U.S.)
    • 7.15.1. OVERVIEW
    • 7.15.2. PRODUCT PORTFOLIO
    • 7.15.3. KEY INNOVATION SECTOR
    • 7.15.4. STRATEGIC INITIATIVES
    • 7.15.5. SCOT ANALYSIS
    • 7.15.6. STRATEGIC ANALYSIS

LIST OF TABLES

  • 1. GLOBAL PREFILLED SYRINGES MARKET BY APPLICATION 2014-2023 ($ MILLION)
  • 2. GLOBAL PREFILLED SYRINGES HARMONAL REPLACEMENT MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 3. GLOBAL PREFILLED SYRINGES DIABETES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 4. GLOBAL PREFILLED SYRINGES ANAPHYLAXIS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 5. GLOBAL PREFILLED SYRINGES ARTHRITIS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 6. GLOBAL PREFILLED SYRINGES ANEMIA MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 7. GLOBAL PREFILLED SYRINGES MULTIPLE SCLEROSIS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 8. GLOBAL PREFILLED SYRINGES MARKET BY MATERIAL 2014-2023 ($ MILLION)
  • 9. GLOBAL PREFILLED SYRINGES GLASS-BASED MARKET BY PRODUCT 2014-2023 ($ MILLION)
  • 10. GLOBAL PREFILLED SYRINGES PLASTIC-BASED MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 11. GLOBAL PREFILLED SYRINGES MARKET BY DISTRIBUTION CHANNEL 2014-2023 ($ MILLION)
  • 12. GLOBAL PREFILLED SYRINGES HOSPITALS MARKET 2014-2023 ($ MILLION)
  • 13. GLOBAL PREFILLED SYRINGES AMBULATORY SURGICAL CENTERS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 14. GLOBAL PREFILLED SYRINGES MAIL ORDER PHARMACIES MARKET 2014-2023 ($ MILLION)
  • 15. NORTH AMERICA PREFILLED SYRINGES MARKET 2014-2023 ($ MILLION)
  • 16. EUROPE PREFILLED SYRINGES MARKET 2014-2023 ($ MILLION)
  • 17. ASIA PACIFIC PREFILLED SYRINGES MARKET 2014-2023 ($ MILLION)
  • 18. REST OF THE WORLD PREFILLED SYRINGES MARKET 2014-2023 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL PREFILLED SYRINGES MARKET BY HORMONAL REPLACEMENT 2014-2023 ($ MILLION)
  • 2. GLOBAL PREFILLED SYRINGES MARKET BY DIABETES 2014-2023 ($ MILLION)
  • 3. GLOBAL PREFILLED SYRINGES MARKET BY ANAPHYLAXIS 2014-2023 ($ MILLION)
  • 4. GLOBAL PREFILLED SYRINGES MARKET BY ARTHRITIS 2014-2023 ($ MILLION)
  • 5. GLOBAL PREFILLED SYRINGES MARKET BY ANEMIA 2014-2023 ($ MILLION)
  • 6. GLOBAL PREFILLED SYRINGES MARKET BY MULTIPLE SCLEROSIS 2014-2023 ($ MILLION)
  • 7. GLOBAL PREFILLED SYRINGES MARKET BY GLASS-BASED 2014-2023 ($ MILLION)
  • 8. GLOBAL PREFILLED SYRINGES MARKET BY PLASTIC-BASED 2014-2023 ($ MILLION)
  • 9. GLOBAL PREFILLED SYRINGES MARKET BY HOSPITALS 2014-2023 ($ MILLION)
  • 10. GLOBAL PREFILLED SYRINGES MARKET BY AMBULATORY SURGICAL CENTERS 2014-2023 ($ MILLION)
  • 11. GLOBAL PREFILLED SYRINGES MARKET BY MAIL ORDER PHARMACIES 2014-2023 ($ MILLION)
  • 12. UNITED STATES (U.S.) PREFILLED SYRINGES MARKET 2014-2023 ($ MILLION)
  • 13. CANADA PREFILLED SYRINGES MARKET 2014-2023 ($ MILLION)
  • 14. UNITED KINGDOM (UK) PREFILLED SYRINGES MARKET 2014-2023 ($ MILLION)
  • 15. FRANCE PREFILLED SYRINGES MARKET 2014-2023 ($ MILLION)
  • 16. GERMANY PREFILLED SYRINGES MARKET 2014-2023 ($ MILLION)
  • 17. SPAIN PREFILLED SYRINGES MARKET 2014-2023 ($ MILLION)
  • 18. ROE PREFILLED SYRINGES MARKET 2014-2023 ($ MILLION)
  • 19. INDIA PREFILLED SYRINGES MARKET 2014-2023 ($ MILLION)
  • 20. CHINA PREFILLED SYRINGES MARKET 2014-2023 ($ MILLION)
  • 21. JAPAN PREFILLED SYRINGES MARKET 2014-2023 ($ MILLION)
  • 22. KOREA PREFILLED SYRINGES MARKET 2014-2023 ($ MILLION)
  • 23. ROAPAC PREFILLED SYRINGES MARKET 2014-2023 ($ MILLION)
  • 24. LATIN AMERICA PREFILLED SYRINGES MARKET 2014-2023 ($ MILLION)
  • 25. MENA PREFILLED SYRINGES MARKET 2014-2023 ($ MILLION)
Back to Top